{"organizations": [], "uuid": "3fae2f0c58fb6002e277cc80c7d50d6eade269f1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-drreddys-laboratories-updates-on-r/brief-dr-reddys-laboratories-updates-on-re-inspection-at-formulations-mfg-plant-in-bachupally-idUSFWN1PJ119", "country": "US", "domain_rank": 408, "title": "BRIEF-Dr.Reddy's Laboratories Updates on Re-inspection At Formulations Mfg Plant In Bachupally", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.889, "site_type": "news", "published": "2018-01-24T21:25:00.000+02:00", "replies_count": 0, "uuid": "3fae2f0c58fb6002e277cc80c7d50d6eade269f1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-drreddys-laboratories-updates-on-r/brief-dr-reddys-laboratories-updates-on-re-inspection-at-formulations-mfg-plant-in-bachupally-idUSFWN1PJ119", "ord_in_thread": 0, "title": "BRIEF-Dr.Reddy's Laboratories Updates on Re-inspection At Formulations Mfg Plant In Bachupally", "locations": [], "entities": {"persons": [{"name": "reddy", "sentiment": "negative"}], "locations": [{"name": "bavaria", "sentiment": "none"}, {"name": "hyderabad", "sentiment": "none"}, {"name": "bachupally", "sentiment": "none"}], "organizations": [{"name": "laboratories ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eu", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Dr.Reddy’s Laboratories Ltd:\n* THERE HAS BEEN RE-INSPECTION BY GERMAN REGULATOR AT CO‘S FORMULATIONS MANUFACTURING UNIT 2 PLANT IN BACHUPALLY, HYDERABAD‍​\n* BETAPHARM INFORMED THAT CURRENT STATUS OF EU GMP NON-COMPLIANCE IS TO BE WITHDRAWN FROM GOVERNMENT. OF UPPER BAVARIA Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T21:25:00.000+02:00", "crawled": "2018-01-25T12:58:29.024+02:00", "highlightTitle": ""}